2Platsouka E, Zissis NP, Portolos J, et al. Bacterial susceptibilities to piperacillin/tazobactam in a tertiary care hospital 5 year rcview[J]. J Chemother,2003,15(1) :27-30.
3Higgins PG,Wisplinghoff H,Stefanik D,et al. In vitro activities of the beta lactamase inhibitors clavulanic acid, sulbaetam, and tazobactam alone or in combination with beta lactams against epidemiologically characterized multidrug-resistant Acinetobacter baumannii strains [ J ]. Antimicrob Agents Chemother,2004,48(5) :1586-1592.
4Megraud F. H pylori antibiotic resistance: prevalence, importance,and advances in testing[J]. Gut,2004,53(9): 1374- 1384.
